SULF2 and cervical carcinoma: As shown by qRT-PCR and immunohistochemistry in Figure 1A, C, and D, the mRNA expression of SULF2 was significantly increased in the tumor tissue of cervical cancer (4.26±0.58) compared with that in the matched non-tumor adjacent tissues (1.16±0.26, P<0.05).